Home > Income Statement > DIVIS LABORATORIES

DIVIS LABORATORIES
Consolidated Net Profit

    Back to Income Statement
DIVIS LABORATORIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best 1M Momentum Large Cap Stocks
AD     Remove this Ad

DIVIS LABORATORIES Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹2,191 Cr₹1,600 Cr₹1,824 Cr₹2,960 Cr₹1,984 Cr

What is the latest Consolidated Net Profit of DIVIS LABORATORIES ?

The latest Consolidated Net Profit ratio of DIVIS LABORATORIES is ₹2,191 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹2,191 Cr
Mar2024₹1,600 Cr
Mar2023₹1,824 Cr
Mar2022₹2,960 Cr
Mar2021₹1,984 Cr

How is Consolidated Net Profit of DIVIS LABORATORIES Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹2,191 Cr
36.94
Mar2024 ₹1,600 Cr
-12.28
Mar2023 ₹1,824 Cr
-38.39
Mar2022 ₹2,960 Cr
49.19
Mar2021 ₹1,984 Cr -

Compare Consolidated Net Profit of peers of DIVIS LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
DIVIS LABORATORIES ₹170,257.2 Cr 1.9% 5.9% 12.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹417,028.0 Cr 0.3% 9% 8.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹146,801.0 Cr 0.6% 9.5% 45% Stock Analytics
CIPLA ₹108,861.0 Cr 1.6% 1.8% -7.9% Stock Analytics
DR REDDYS LABORATORIES ₹107,435.0 Cr -1.5% 5.7% 14.5% Stock Analytics
MANKIND PHARMA ₹92,784.1 Cr 9.9% 5.8% -2% Stock Analytics


DIVIS LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
DIVIS LABORATORIES

1.9%

5.9%

12.6%

SENSEX

-1.8%

-1.6%

7.3%


You may also like the below Video Courses